GSK FINANCE (NO.3) LIMITED - Profile & Financials

Accounts Submitted

Confirmation Statement Submitted

Net assets £117.40K £10.94K 2022 year on year

Total assets £117.40K £290.46K 2022 year on year

Total Liabilities £0.00 £278.92K 2022 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

C/O Bdo Llp 5 Temple Square Temple Street Liverpool L2 5RH

Credit Report

Discover GSK FINANCE (NO.3) LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2022

Type Total Exemption Full

Next accounts 31 December 2023

Due by 30 September 2024 9 months

Net Assets, Total Assets & Total Liabilities (2021–2022)

Cash in Bank

£116.41k

Decreased by £183.66k (-61%)

Net Assets

£117.40k

Decreased by £10.94k (-9%)

Total Liabilities

N/A

Decreased by £278.92k (-100%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 68 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2022 Dec Year End	2021 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

5 active 1 resigned

Show resigned officers

						Status
Alistair Robert Davidson	Director	British	England	53	21 May 2020	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	21 May 2020	Active
Peter Kenneth Hopkins	Director	British	United Kingdom	53	21 May 2020	Active
The Wellcome Foundation Limited	Corporate-director	United Kingdom	Unknown	—	21 May 2020	Active
Victoria Anne Whyte	Secretary	Unknown	Unknown	—	21 May 2020	Active

Shareholders

Shareholders (1)


Glaxo Group Limited	100.0%	50,001	Ordinary	20 Jul 2021

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxo Group Limited

United Kingdom

Active

Notified 21 May 2020

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

GSK FINANCE (NO.3) LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
17 Nov 2025	Insolvency	Liquidation Voluntary Members Return Of Final Meeting	View(18 pages)
17 Jun 2025	Insolvency	Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date	View(17 pages)
23 Sept 2024	Officers	Change Person Secretary Company With Change Date	View(1 page)
3 Jun 2024	Insolvency	Liquidation Voluntary Declaration Of Solvency	View(6 pages)
3 Jun 2024	Insolvency	Liquidation Voluntary Appointment Of Liquidator	View(3 pages)